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Open acAbstract Background and aims: Studies have consistently demonstrated that variants in
a number of candidate genes are significant determinants of lipid levels in adults. However,
few studies have investigated the impact of these variants in children. Therefore, in the
present investigation we examined the influence of ten common variants in the genes for lipo-
protein lipase (LPL e S447X), cholesterol ester transfer protein (CETP e Taq1B) apolipoprotein
(APO) E (32, 33, 34), APOA5 (1131C> T and S19W), APOA4 (S347T) and APOC3 (482C> T;
1100C> T and 3238G> C) on lipoprotein levels children from the GeneeDiet Attica Investiga-
tion on childhood obesity (GENDAI).
Methods and results: The ten variants selected were genotyped in 882 Greek children, mean
age: 11.2 0.7 years (418 females and 464 males). Genotypes were assessed using TaqMan
technology. Significantly higher total cholesterol (TC) (pZ 0.0001) and low-density lipoprotein
cholesterol (LDL-C) (p< 0.0001) were observed in APOE 34 carriers compared to 33/33 homo-
zygotes and 32 carriers. The association of APOE genotype with TC and high-density lipoprotein
cholesterol (HDL-C) ratio (pZ 0.0008) was further modulated by body mass index. Carriers of
the CETP TaqIB B2 allele had significantly higher HDL-C (p< 0.0001) and significantly lowerGENDAI, GeneeDiet Attica Investigation on childhood obesity; APO, apolipoprotein; TG, triglyceride;
terol ester transfer protein; BMI, body mass index; SNPs, single nucleotide polymorphisms; HWE,
l cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol;
1, first principal component; PC2, second principal component; MAF, minor allele frequency; GWAS,
L, triglyceride rich lipoproteins; NS, not statistically significant; CI, confidence intervals; IQR, inter
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APOE, CETP and LPL genes show strong association with lipid levels 27TC: HDL-C ratio (p< 0.0001) compared to B1/B1 individuals. No significant associations were
observed between APOA4, APOA5 and APOC3 variants and serum lipids.
Conclusion: This study demonstrates that these common variants are associated with lipid
levels in this healthy paediatric cohort, suggesting that even in these young children there
may be potential in predicting their lifelong exposure to an adverse lipid profile.
ª 2009 Elsevier B.V. Open access under CC BY license.Introduction
In parallel with the increase in adult obesity, childhood
obesity is a rapidly growing health problem worldwide [1].
Obesity in childhood is linked to many serious health
complications usually seen in adulthood [2]. Co-morbidities
include elevated blood pressure, increased prevalence of
factors associated with type 2 diabetes (T2D) and lipid
abnormalities [1]. The GeneeDiet Attica Investigation on
childhood obesity (GENDAI) [3] was established to specifi-
cally explore the contribution of genetics and environ-
mental factors in the development of childhood obesity.
The GENDAI cohort consists of young children of both sexes
attending school in the area of Attica, Greece. Preliminary
assessment provided the impetus for a more detailed study
of the metabolic syndrome phenotype in the GENDAI cohort
with particular focus on the genetic contribution to inter-
individual variation in plasma lipids in the young and the
potential modulation of these genetic associations by
environmental influences.
Genetic factors are considered to be important deter-
minants of plasma lipoprotein levels in adults; however, the
role of genetics in determining plasma lipoproteins in
children and adolescents is less clear. The apolipoprotein
(APO) cluster including APOA5, APOAIV, APOC3 and APOA1
on chromosome 11 is associated with variation in triglyc-
erides (TG) in both children and adults and across a range of
ethnic groups [4,5]. Variation in the APOE, lipoprotein
lipase (LPL) and cholesterol ester transfer protein (CETP)
genes has been consistently associated with variation in
lipid levels in adults [6,7]. However, genetic variation in
these gene loci explain only a modest proportion of inter-
individual variability in fasting lipid levels [8]. We geno-
typed the GENDAI cohort for ten variants in the APOE, LPL,
CETP genes and the APOA5/A4/C3 cluster, to examine if the
reported effects could be replicated in children and assess
if these associations could be further modulated by body
mass index (BMI).
Methods
Study population
Participants were drawn from the children recruited in the
GENDAI study. Briefly, a random sample of 2492 children
attending school in the Attica region in Greece were invited
to join the study. A total of 1138 children were recruited
from November 2005 to June 2006. Due to the heteroge-
neity in allele frequencies between Greek and non-Greek
Caucasians, only children of Greek nationality, mean age:
11.2 0.7 years (nZ 882; 418 males and 464 females),
were included in the present study. Details of recruitmentand data collection have been previously described [3]. All
persons gave their informed consent prior to inclusion in
the study. The study was approved by the Institutional
Review Board of Harokopio University and the Greek
Ministry of Education [3].
Experimental procedures
Single nucleotide polymorphism selection and
genotyping
A salting-out procedure [9] was used to isolate DNA samples
from whole blood. Ten single nucleotide polymorphisms
(SNPs) in six candidate genes; LPL S447X (rs328), CETP
Taq1B (rs708272), APOE (rs7412, rs429358), APOA5
1131C> T (rs662799) and S19W (rs3135506), APOA4 S347T
(rs675) and APOC3 482C> T (rs2854117), 1100C> T
(rs4520) and 3238C> G (rs5128) were genotyped using
TaqMan technology (Applied Biosciences, ABI, Warrington
UK). Reactions were performed on 384-well microplates
and analysed using ABI TaqMan 7900HT software. Primers
and MGB probes are available upon request.
Statistical methods
HardyeWeinberg equilibrium (HWE) was examined by chi-
square goodness of fit test. A p value of <0.05 was taken as
deviation from HWE. Plasma levels of insulin, TG, total
cholesterol (TC), low-density lipoprotein cholesterol (LDL-
C) and high-density lipoprotein cholesterol (HDL-C) and all
anthropometric measures were natural log-transformed.
For association studies a p value of <0.01 was taken as
statistically significant. Setting a threshold of significance
was the chosen method above Bonferroni corrections, since
the candidate genes studied had been selected for based on
a priori hypothesis and biological plausibility. A p value of
<0.05 was taken as statistically significant in Principal
Component Analysis (PCA). The majority of statistical
analyses were performed using Intercooled Stata 8.2 for
Windows (StataCorp LP, Texas, USA). Haplotype association
analysis was carried out using Thesias [10]. PCA was carried
out using SAS (SAS Institute Inc., Cary, NC). Throughout this
study we used the first principal component (PC1) and the
second principal component (PC2) because both compo-
nents explained more than 80% of the variation and their
eigenvalues were greater than the average eigenvalue [11].
Results
Subjects were classified as obese, overweight and non-
overweight according to the International Obesity Task
28 M.C. Smart et al.Force [12]. The non-overweight group includes normal
weight (nZ 533) and underweight (nZ 2) children and
for the purposes of this study has been called the normal
weight group (nZ 535). Table 1 summarises the baseline
characteristics of a selection of lipid and anthropometric
measures, comparing the overweight and obese children
(nZ 343) in the study to their normal weight counter-
parts (nZ 535). Measures of blood pressure, insulin, TG,
height and insulin resistance were significantly higher
(p< 0.0001) and HDL-C significantly lower (p< 0.0001)
in the overweight and obese group compared to their
normal weight counterparts. The mean BMI of the
mothers and fathers of the children was 24.6 4.8 and
27.2 3.6, respectively. Children whose parents were
both overweight (BMI 25) had a BMI 2.2 units larger than
children whose parents were both of a normal weight
(BMI< 25) (p< 0.00001) (Appendices Table 1a). Children
of parents who were hypercholesterolemic (Cholesterol
>240 mg/dl) had significantly higher cholesterol levels
compared to children of parents who’s cholesterol levels
were normal (p< 0.00001) and the same observation
was observed between parents and their children with
LDL levels (pZ 0.003) (Appendices Table 1c and 1b,
respectively).Table 1 Comparisons between normal weight and overweight/
Variable Normal-weight
Gender (male/female) (%male) 236/297 (44.1%)
Age (years) 11.2 0.6d
Tanner genitals or breast score 2 (IQR 2e3)e
Tanner pubic hair score 2 (IQR 2e3)e
Variable Normal weightf
Weight (kg) 39.1 (38.6, 39.6)
Height (cm) 147.8 (147.2, 148.4)
Waist circumference (cm) 63.5 (63.0, 64.0)
Triceps skin fold (mm) 15.0 (14.6, 15.4)
Subscapular skin fold (mm) 8.2 (8.0, 8.4)
Body fatness % (Slaughter eq.) 21.8 (21.3, 22.3)
Systolic blood pressure (mmHg) 117.2 (116.0, 118.5)
Diastolic blood pressure (mmHg) 72.8 (71.8, 73.9)
Insulin (uIU/mL) 5.8 (5.6, 6.1)
Glucose (mg/dL) 85.2 (84.4, 86.0)
Insulin resistance (HOMAIR-IR) 1.22 (1.16, 1.28)
TG (mmol/L) 0.63 (0.61, 0.65)
TC (mmol/L) 4.79 (4.72, 4.86)
HDL-C (mmol/L) 1.38 (1.36, 1.41)
LDL-C (mmol/L) 3.07 (3.02, 3.13)
Birthweight (g) 3241.6 (2167.67, 4184.40)
NS, not statistically significant; TG, total triglyceride; TC, total chol
density lipoprotein cholesterol; IQR, inter quartile range and CI, confi
a Overweight and obesity were defined according to the Internat
reference values.
b Assessed by ANOVA.
c Assessed by c2.
d Mean (standard deviation).
e Median (IQR).
f Mean (95% CI).
g Assessed by linear regression, adjusted for Tanner status and genGenotype frequencies
There were no allele frequency differences between boys
and girls for any of the ten variants (data not shown). The
genotype and minor allele frequency (MAF) for the ten
variants are shown in Table 2. The genotype distribution of
APOC3 1100C> T deviated from those expected under HWE
(pZ 0.02). There was a borderline statistically significant
difference in allele frequency distribution of the LPL S447X
variant between normal weight children and their over-
weight and obese counterparts, MAF 0.14 (95% confidence
intervals (CI) 0.11, 0.16) vs. 0.11 (95% CI 0.08, 0.14)
(pZ 0.02).
Association with quantitative traits
Significant data for lipid and anthropometric variables,
according to genotype, are presented in Table 3. APOE
genotype, defined by two variant sites at residues 112 and
158 creating the 32, 33 and 34 alleles, was significantly
associated with TC (pZ 0.0001) with 32 carriers having TC
plasma levels 11.3% lower than 33/33 subjects (p< 0.001)
and 34 carriers with 1.3% higher TC plasma levels than 33/33
subjects (pZ 0.522). APOE genotype was also significantlyobesea subjects.
n Overweight and obese n p value
535 180/163 (52.5%) 343 0.015c
534 11.1 0.6d 340 NSb
532 3 (IQR 2e3)e 338 0.06c
532 2 (IQR 2e3)e 338 NSc
n Overweight and obesef n p valueg
535 53.1 (52.2, 53.9) 343 <0.0001
535 150.8 (149.3, 150.0) 343 <0.0001
535 77.1 (76.1, 77.9) 342 <0.0001
535 25.7 (25.1, 26.4) 340 <0.0001
535 16.0 (15.5, 16.6) 340 <0.0001
455 39.1 (37.9, 40.4) 270 <0.0001
531 123.9 (122.2,125.5) 340 <0.0001
529 77.6 (76.2, 79.0) 340 <0.0001
513 8.8 (8.3, 9.3) 325 <0.0001
525 84.6 (83.6, 85.6) 332 NS
512 1.84 (1.73, 1.96) 332 <0.0001
526 0.75 (0.75, 0.81) 332 <0.0001
526 4.81 (4.72, 4.89) 332 NS
526 1.27 (1.24, 1.29) 332 <0.0001
526 3.13 (3.06, 3.21) 332 NS
467 3297.3 (2319.14, 4403.03) 305 NS
esterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-
dence intervals.
ional Obesity Task Force recommendations, using international
der.
Table 2 Allele and genotype frequencies of candidate gene variants in Greek children.
Gene rs Number AA and nucleotide change Genotype n % MAF (95% CI)
CETP 708272 Taq1B G> A GG-B1/B1 252 35.44 0.4
GA-B1/B2 351 49.37 (0.37, 0.42)
AA-B2/B2 108 15.19
APOE 429358 C112R C112/C158-32 34 7.78 32 0.09
7412 R158C C112/R158-33 335 76.66 (0.07, 0.10)
R112/R158-34 68 15.56 34 0.14
(0.10, 0.18)
APOC3 2854117 482C> T CC 304 48.41 0.31
CT 262 41.72 (0.28, 0.33)
TT 62 9.87
APOC3 4520a 1100C> T CC 321 50.63 0.28
CT 277 43.69 (0.25, 0.30)
TT 36 5.68
APOC3 5128 Sst1 GG-S1S1 477 76.44 0.13
3238G> C GC-S1S2 137 21.96 (0.11, 0.14)
CC-S2S2 10 1.6
APOA4 675 S347T TT 352 57.8 0.24
AT 221 36.29 (0.22, 0.26)
AA 36 5.91
APOA5 662799 1131T> C TT 556 84.5 0.08
TC 97 14.74 (0.07, 0.10)
CC 5 0.76
APOA5 3135506 S19W GG 582 90.23 0.05
GC 62 9.61 (0.04, 0.06)
CC 1 0.16
LPL 328 S447X CC 540 76.49 0.13
CG 154 21.81 (0.11, 0.14)
GG 12 1.7
AA, amino acid; MAF, minor allele frequencie; CI, confidence intervals; APO, apolipoprotein; LPL, lipoprotein lipase and CETP,
cholesterol ester transfer protein.
a Borderline deviation from HardyeWeinberg Equilibrium (pZ 0.02).
APOE, CETP and LPL genes show strong association with lipid levels 29associated with LDL-C (p< 0.0001). 32 carriers had LDL-C
plasma levels that were 17.6% lower than 33/33 subjects
(p< 0.001) and 34 carriers had a mean LDL-C plasma level
that was 2.8% higher than 33/33 subjects (pZ 0.258). 32
carriers were also observed with a significantly lower mean
TC: HDL-C ratio of 3.26 (95% CI 3.1, 3.5) compared to 3.62
(95% CI 3.6, 3.7) and 3.81 (95% CI 3.7, 4.0) for 33/33 and 34
carriers, respectively (pZ 0.0008). The CETP Taq1B variant
was associated with significantly higher HDL-C (p< 0.0001)
and lower TC: HDL-C ratio (p< 0.0001) in those who were
carriers or homozygotes for the B2 allele.
The LPL S447X variant showed borderline significant
association with weight (pZ 0.02) with 447X homozygotes
weighing almost 5 kg less than S447 homozygotes. Carriers
of the APOA5 19W had 7.8% higher plasma TG levels
compared to homozygotes for the common allele, but the
association did not reach statistical significance (pZ 0.038)
(Appendices Table 2). Carriers of the APOA5 1131 rare T
allele had 6.1% higher TG levels compared to CC homozy-
gotes, but again this did not reach statistical significance
(pZ 0.048) (Appendices Table 2). No significant associa-
tions were observed between the APOA4 T347S and APOC3variants and serum lipids. Common haplotypes within the
APOA5/A4/C3 cluster showed no significant effect on TG,
TC HDL-C or LDL-C levels (Appendices Table 2).
Principal component analysis
The plasma and anthropometric measures used for PCA
were combined based on their correlation structures
(Appendices Table 3). The first PCA included HDL-C, TC and
LDL-C with PC1 explaining 74% of the variation and PC2 an
additional 25% of the variation. CETP Taq1B and APOE were
identified as having a significant effect in both PC1
(p< 0.01) and PC2 (p< 0.001) (Table 4a). The second PCA
included weight, waist circumference, hip circumference,
triceps and subscapular skin folds. PC1 alone explained 84%
of the total variation, identifying LPL S447X as significant
(pZ 0.04) (Table 4b). The final PCA combined measures of
TG, insulin and insulin resistance with PC1 explaining 72% of
the variation and PC2 explaining an additional 27%. PC2
identified the two variants in APOA5, 1131C> T and S19W
as having a significant effect (pZ 0.015 and pZ 0.039,
respectively) (Table 4c).
Table 3 Association of APOE, CETP Taq1B and LPL S447X with baseline plasma and anthropometric measures.
APOE Genotype (n) LDL-C (mmol/L)a TC (mmol/L)b TC: HDL-C Ratioc
Mean (95% CI) Mean (95% CI) Mean (95% CI)
32 Carriers (33) 2.58 (2.41, 2.76) 4.27 (4.04, 4.49) 3.29 (3.11, 3.48)
33/33 (332) 3.13 (3.07, 3.20) 4.82 (4.74, 4.90) 3.62 (3.56, 3.67)
34 Carriers (67) 3.22 (3.07, 3.37) 4.88 (4.70, 5.07) 3.78 (3.62, 3.93)
p value <0.0001 0.0001 0.0008
CETP TAQ1B Genotype (n) HDL-C (mmol/L)d TC: HDL-C ratioc
Mean (95% CI) Mean (95% CI)
B1B1 (248) 1.27 (1.24, 1.30) 3.75 (3.67, 3.83)
B1B2 (348) 1.37 (1.34, 1.40) 3.53 (3.47, 3.60)
B2B2 (108) 1.40 (1.35, 1.46) 3.45 (3.35, 3.56)
p value <0.0001 <0.0001
LPL S447X Genotype (n) Weight (kg)e
Mean (95% CI)
SS (534) 44.25 (43.65, 44.87)
SX (151) 43.30 (42.21, 44.40)
XX (12) 39.42 (35.98, 43.20)
p value 0.02
APO, apolipoprotein; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; CI,
confidence intervals; TG, total triglyceride; LPL, lipoprotein lipase; CETP, cholesterol ester transfer protein and BMI, Body mass index.
Only data with p values 0.02 has been presented. Tanner status was combined into one variable from the two Tanner measures to
produce a mean Tanner score.
a Adjusted for height.
b Adjusted for height and gender.
c Adjusted for gender, mean Tanner score and BMI.
d Adjusted for height, gender and BMI.
e Adjusted for height, mean Tanner score and gender.
30 M.C. Smart et al.APOE variation interacts with BMI impacting on
lipid measures
An interaction of APOE and BMI (dichotomised into Normal
weight and Overweight/Obese) was impacting on the TC:
HDL-C ratio in this young cohort (pZ 0.008) was identified
(Fig. 1a) and HDL-C levels (pZ 0.01) (data not shown). 34
carriers in the overweight and obese category had a poorer
TC: HDL-C ratio of 4.3 (95% CI 4.0, 4.6) compared to 32
carriers with a ratio of 3.2 (95% CI 2.9, 3.5). Children in the
normal weight category had a TC: HDL-C ratio which was
unaffected by APOE genotype. 34 carriers had a mean ratio
of 3.6 (95% CI 3.4, 3.8), 33/33 3.5 (95% CI 3.4, 3.6) and 32
carriers 3.3 (95% CI 3.1, 3.6). There was no interaction
between BMI and APOE genotype on plasma LDL-C (Fig. 1b);
TG or TC levels (data not shown). Geneediet interactions
examining all variants with a number of dietary measures
were investigated, but there were no significant results
(data not shown).
Discussion
The results from this study demonstrate in this dataset of
healthy Greek children, the significant association of
candidate gene variants with baseline anthropometric and
lipid measures. More than a third of the children in this
cohort were overweight with obesity reaching a level of9.5%. This is comparable to a study in central Greece
assessing 11-year-olds weight status where a total of 30.3%
were reported to be overweight and 6.7% obese [13]. The
fact that parental BMI was positively associated with their
child’s BMI highlights the importance of family history and
environment in the development of obesity. The over-
weight and obese children in the current study had signifi-
cantly higher arterial blood pressure, lower HDL-C levels,
higher TG and increased insulin compared to their the
normal weight counterparts. Higher Tanner scores and
heights of the overweight and obese group also suggest
earlier onset of puberty, which is often frequently observed
in overweight and obese children [14]. Any interaction
between sexual maturity and effects of allelic variation on
lipid levels that may have occurred could be accounted for
in analyses from the Tanner measures.
Genetic factors are considered important determinants
of plasma lipid levels in adults, demonstrated in several of
the recent genome wide association studies (GWAS) in
which a number of candidate genes have been confirmed
[15,16]. The meta-analysis of 3 GWAS by Willer et al. (2008)
identified strong associations with variants in APOA5/A4/
C3/A1 cluster, APOE, CETP and LPL influencing plasma lipid
concentrations. Although a number of associations compa-
rable to those seen in adults were confirmed in this study,
the role of genetic factors in the heterogeneity of plasma
lipid levels in children is less clear. Replication of these
variants in cohorts of children is needed.
Table 4 Principal component analysis.
Variant PC1 (74%) PC2 (27%)
F value p value F value p value
CETP Taq1B 3.38 0.006 28.01 <0.001
APOE 8.21 0.004 13.05 <0.001
a) HDL-C e LDL-C e TC
Variant PC1 (84%)
F value p value
LPL S447X 4.24 0.04
b) Weight e Waist e Hip e Triceps and Subscapular
skin folds
Variant PC1 (72%) PC2 (25%)
F value p value F value p value
APOA5 S19W 1.52 0.218 4.29 0.039
APOA5 1131C> T 0.07 0.798 5.93 0.015
c) TG e insulin e insulin resistance
Principal component analysis was performed on three separate
clusters. a) HDL-C, LDL-C and TC; b) weight, waist circumfer-
ence, hip circumference, triceps skin fold and subscapular skin
folds; c) TG, insulin and insulin resistanceHOMA. The variance for
the first and second principal components (PC1 and PC2) is
provided; F and p values are provided for each of the significant
variants. LPL, lipoprotein lipase; HDL-C, high-density lipopro-
tein cholesterol; LDL-C; low-density lipoprotein cholesterol;
TC, total cholesterol; CETP, cholesterol ester transfer protein;
APO, apolipoprotein and TG, total triglyceride.
Figure 1 a) Interaction between APOE genotype and BMI
category on total cholesterol/HDL-C ratio (pZ 0.008). Normal
weight children: 33/33Z 195, 32 carriersZ 20, 34 car-
riersZ 43; Overweight and obese children: 33/33Z 139, 32
carriersZ 14, 34 carriersZ 25. b) Interaction between APOE
genotype and BMI category on plasma LDL-C (Not significant).
Normal weight children: 33/33Z 195, 32 carriersZ 19, 34
carriersZ 43; Overweight and obese children: 33/33Z 136, 32
carriersZ 14, 34 carriersZ 2. APO, apolipoprotein; BMI, body
mass index; HDL-C, high-density lipoprotein cholesterol, and
LDL-C, low-density lipoprotein cholesterol.
APOE, CETP and LPL genes show strong association with lipid levels 31In GENDAI, APOE genotypes were associated with
differences in TC and LDL-C plasma levels and the TC: HDL-
C ratio. The LDL-C and TC lowering effect of the 32 allele
reported in the recent meta-analysis [17] was also observed
in this cohort of young Greek children. Carriers of the 34
allele had LDL-C and TC levels that were 19.9% and 12.2%
higher than carriers of the 32 allele and 2.8% and 1.3%
higher than 33/33 subjects. The results of a 21-year longi-
tudinal study on changes in serum lipids in 1233 Finns fol-
lowed from childhood to adulthood consistently observed
the 32 allele to be associated with lower LDL-C levels and
the 34 allele with higher TC and LDL-C levels (p< 0.001 for
all associations) in childhood. The LDL-C-lowering effect of
the 32 allele was an association that was tracked through to
adulthood, having a greater effect with increasing age
(pZ 0.039). The association of the APOE genotype with
plasma TC and LDL-C has been reported in children as young
as 3 years old [18]. The fact that differences in lipid levels
cannot be detected in children at birth by the APOE geno-
type leads to the conclusion that lipid levels are influenced
by genetic and environmental factors in a child’s very first
years of life [18].
CETP is involved primarily in the transfer of lipids in
reverse cholesterol transport, exchanging cholesterol from
HDL-C for TG from TG-rich lipoproteins (TGRL) [19], thus
influencing the TG content of TGRL particles and playing
a major role in the determination of HDL-C levels [20].
Meta-analysis of CETP Taq1B has consistently shown asso-
ciation with HDL-C levels [21]. The association of the B2allele with higher HDL-C levels was observed in this study.
Homozygotes for the B2 allele had approximately 10%
higher mean HDL-C levels compared to the B1/B1 individ-
uals, comparable to that seen in adults [22]. A highly
significant association of the Taq1B variant with TC: HDL-C
ratios in the cohort were also observed, highlighting the
importance of this particular genotype and its effects on
HDL-C levels from a young age. In a cohort of 257 Dutch
prepubescent boys and girls (aged 6.7e8.1 years) the same
association with the Taq1B variant was reported, but
dependant on APOE genotype [23].
LPL is a key lipolytic enzyme that plays a crucial role in
the catabolism of triglycerides in TG-rich particles and the
S447X variant in exon 9 results in premature truncation
[24]. The LPL 447X genotype has been consistently associ-
ated in adult populations with a beneficial lipid profile
conferring a protective effect against myocardial infarction
[25]. Children homozygous for the rare 447X allele had
approximately 2% lower TG levels than children who were
homozygous for the common allele, but this did not reach
statistical significance. The borderline association of the
447X allele with lower weight is interesting considering
the significant difference in MAF (pZ 0.02) between the
32 M.C. Smart et al.normal weight and overweight children (MAF 0.14 and 0.11,
respectively).
Numerous studies have investigated the association of
genetic variation in the APOA5/A4/C3/A1 cluster on lipid
levels in adults [5,26]. The TG raising effect of the APOA5
S19W variant seen in adults was also observed in this
cohort, but this did not reach statistical significance.
Previous studies have shown significant associations of the
APOA5 1131T> C promoter variant with TG levels [5], and
although the association of this variant in the present study
was not statistically significant, TG levels were 6.1% higher
in children who were carriers of the rare allele. There was
no significant association with any of the baseline lipid
measures with the APO4 and three APOC3 variants exam-
ined. These findings corroborate with the data on the
association of variants in the APOC3 gene with lipid levels in
children in the Columbia Biomarkers Study [27]. Although,
trends were observed with the APOC3 variants they did not
reach statistical significance. In particular, carriers of the
S2 allele of the APOC3 Sst1 variant was associated with
higher TG levels, which is consistent with the recently
published AVENA Study [28]. The lack of association in the
case of both the APOA5 and APOC3 variants was due to
insufficient power to detect the modest effect size these
variants were having on TG levels. PCA was adopted to
increase the power of detecting such associations, but did
not provide any information over and above the results
from the regression analysis, but all associations were
confirmed. As well as the association of these variants with
lipid levels, it is of importance that the effect and influence
of these variants on plasma apolipoprotein levels is also
investigated. In the present study we unfortunately did not
have these measures.
Increased levels of obesity have been demonstrated to
amplify genetic effects. Even in these young children, BMI
through an interaction with APOE was modulating and
determining the lipid parameters of the TC: HDL-C ratio,
with the less beneficial ratio being found among 34 carriers
than among 33/33 or 32 carriers. The APOE genotype had
little influence on the TC: HDL-C ratio in children of
a normal BMI. A similar association was seen in a cohort of
266 healthy men with APOE 32, 33, 34 genotype and TC,
LDL-C and insulin levels. Individuals who were 34 carriers
had significantly higher (pZ 0.04) TC, LDL-C and insulin
levels compared 33/33 or 32 carriers, an association which
was enhanced in the 34 carriers as BMI increased [29].
These data suggest that effects of APOE alleles on lipids
levels are partly dependent on and modulated by environ-
mental variables such as BMI.
Previous genetic studies have demonstrated that vari-
ants investigated in this study are significant determinants
of serum lipid levels in adults. However, only a few studies
have investigated the association of these variants in
children. The effects in the GENDAI study are of similar
magnitude to those observed in adults, suggesting that
even in these young children there is potential in pre-
dicting their long-term exposure to an adverse lipid
profile. Kathiresan et al. have developed a genotype score
for use in CHD risk assessment [30]. Using 9 SNPs in genes
that determining plasma LDL and HDL cholesterol levels,
they reported that addition of a genotype score to a CHD
risk algorithm improved risk reclassification, even afteradjustment for baseline lipid levels. This result impor-
tantly suggested that lipid-associated SNPs may provide
incremental information about an individuals’ risk beyond
a single lipid measure and furthermore, although indi-
vidual SNPs exert only a modest affect on lipid variation,
in combination they may have a substantial influence. The
data from this present study suggest the influence of
variants is exerted at a very young age, and thus reflecting
a lifelong exposure.Acknowledgements
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